Pharmacogenomics of adrenoceptors

Pharmacogenomics

Volumn 5, Issue 7, 2004, Pages 803-817

  Flordellis, C ^a   Paris, H ^b   Karabinis, A ^c   Lymperopoulos, A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b CHU RANGUEIL   (France)

^c KAT HOSPITAL   (Greece)

Author keywords

Adrenoceptor; Pharmacogenomics; Polymorphism; Polymorphism combination; Receptor haplotypes

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR KINASE; METOPROLOL; NORADRENALIN; RECEPTOR SUBTYPE;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; CARBOXY TERMINAL SEQUENCE; DISEASE PREDISPOSITION; DRUG POTENCY; ENZYME PHOSPHORYLATION; ESSENTIAL HYPERTENSION; EXON; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HEART FAILURE; HUMAN; NONHUMAN; OPEN READING FRAME; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VASOCONSTRICTION;

ANIMALS; HUMANS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC; VARIATION (GENETICS);

EID: 6344294233     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.5.7.803     Document Type: Review

References (118)

1. Bylund DB, Eikenberg DC, Hieble JP et al.: International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46, 121-136 (1994).
2. Spiegel AM: Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58, 143-170 (1996).
3. Small KM, McGraw DW, Liggett SB: Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43, 381-411 (2003).
4. Ferguson SS: Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53, 1-24 (2001).
5. 1-adrenoceptor pharmacology. Biol. Pharm. Bull. 25, 401-408 (2002).
6. 1A-Adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br. J. Pharmacol. 118, 1403-1408 (1996).
7. 1A-Adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics 9, 651-656 (1999).
8. 1A adrenoceptor gene polymorphism and clozapine-induced urinary incontinence. Neuropsychobiology 42, 62-65 (2000).
9. 2-adrenoreceptors on haemodynamic responses to adrenaline. Clin. Sci. (Lond.) 104, 509-520 (2003).
10. Zagato L, Modica R, Florio M et al.: Genetic mapping of blood pressure quantitative trait loci in Milan hypertensive rats. Hypertension 36, 734-739 (2000).
11. 1B-adrenergic receptor polymorphisms. J. Pharmacol. Exp. Ther. 291,793-798 (1999).
12. McCaffery JM, Pogue-Geile MF, Ferrell RE, Petro N, Manuck SB: Variability within α- and β-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge. J. Hypertens. 20, 1105-1114 (2002).
13. 1-Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J. Mol. Med. 78, 87-93 (2000).
14. 1-adrenergic receptor gene (-93C>T, -210C>T, and -2146T>C): -2146C homozygotes present in patients with idiopathic dilated cardiomyopathy and coronary heart disease. Hum. Mutat. 16, 534 (2000).
15. 1-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G> C. Hum. Mutat. 14, 271 (1999).
16. 1-adrenergic receptor affect agonist-promoted trafficking. J. Cardiovasc. Pharmacol. 39, 155-160 (2002).
17. 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J. Biol. Chem. 277, 30429-30435 (2002).
18. 1-adrenergic receptor. J. Biol. Chem. 274, 12670-12674 (1999).
19. 1-adrenoceptors in isolated human atrial myocardium. Br. J. Pharmacol. 138, 386-392 (2003).
20. 1-adrenergic receptor polymorphisms in human right atrium in vitro. J. Am. Coll. Cardiol. 40, 1275-1282 (2002).
21. 1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int. J. Obes. Relat. Metab. Disord. 25, 1599-1603 (2001).
22. 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin. Pharmacol. Ther. 74, 44-52 (2003).
23. 1-adrenergic receptor gene and hypertension. Circulation 104, 187-190 (2001).
24. 1-adrenergic receptor predict exercise capacity in heart failure. Am. Heart. J. 144, 840-846 (2002).
25. 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11, 191-197 (2001).
26. 1-adrenoceptor polymorphism in humans. Pharmacogenetics 11, 199-205 (2001).
27. 1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. Clin. Sci. (Lond.) 99, 233-238 (2000).
28. 2C-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 347, 1135-1142 (2002).
29. 1-Adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat. Med. 9, 1300-1305 (2003).
30. 1-adrenergic receptor is associated with resting heart rate. Am. J. Hum. Genet. 70, 935-942 (2002).
31. 1-adrenergic receptor associated with survival in patients with heart failure. Eur. Heart J. 21, 1853-1858 (2000).
32. 1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin. Pharmacol. Ther. 74, 372-379 (2003).
33. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13, 25-33 (1995).
34. 2-adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 9, 511-516 (1999).
35. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. USA 97, 10483-10488 (2000).
36. 2-adrenergic receptor mRNA inhibits receptor synthesis. J. Biol. Chem. 269, 4497-4505 (1994).
37. 2-adrenergic receptor regulate receptor expression, J. Clin. Invest. 102, 1927-1932 (1998).
38. 2-Adrenergic receptor 5′ haplotypes influence promoter activity. Br. J. Pharmacol. 137, 1213-1216 (2002).
39. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268, 23116-23121 (1993 ).
40. 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10483-10488 (1996 ).
41. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8, 334-339 (1993).
42. Taylor DR, Kennedy MA: β-Adrenergic receptor polymorphisms and drug responses in asthma. Pharmacogenomics 3, 173-184 (2002).
43. 2-Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33, 1425-1430 (1999).
44. 2-Adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am. Heart J. 139, 537-542 (2000).
45. 2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36, 371-375 (2000).
46. 2-adrenergic receptor on agonist-mediated vascular desensitization. N. Engl J. Med. 345, 1030-1035 (2001).
47. 2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin. Am. J. Hypertens. 14, 1196-1200 (2001).
48. 2-Adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 35, 555-560 (2000).
49. 2-Adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 41,361-367 (2003).
50. 2-adrenoceptor function. J. Clin. Invest. 100, 3005-3013 (1997).
51. 2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin. Genet. 61, 305-307 (2002).
52. 2-adrenoceptor gene polymorphism on obesity in males and in females. J. Intern. Med. 245, 253-259 (1999).
53. 2-adrenergic receptor gene and lipid metabolism during exercise in obese women. Int. J. Obes. Relat. Metab. Disord. 26, 1434-1441 (2002).
54. 2-adrenergic receptor gene in healthy Japanese men is associated with the change of fructosamine level caused by exercise. Diabetes Res. Clin. Pract. 64, 207-212 (2004).
55. 2-Adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 353, 896 (1999).
56. 2-adrenergic receptor gene polymorphism in obesity and Type 2 diabetes mellitus in Korean subjects. Metabolism 51, 833-837 (2002).
57. 2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. Int. J. Obes. Relat. Metab. Disord. 24, 388-390 (2000).
58. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D: β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 13, 379-382 (2003).
59. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest. 102, 1534-1539 (1998).
60. 3-adrenergic-receptor gene. N. Engl. J. Med. 333, 343-347 (1995).
61. 3-adrenergic receptor gene in Japanese subjects. Metabolism 46, 199-202 (1997).
62. 3-adrenoceptor activity. Eur. J. Biochem. 247, 1174-1179 (1997).
63. 3-adrenergic receptor. Jpn. J. Pharmacol. 88, 314-318 (2002).
64. 3-adrenergic receptor is not associated with Type II diabetes or obesity in a large Finnish sample. Diabetologia 42, 238-244 (1999).
65. 3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes. Res. 9, 741-745 (2001).
66. 2-adrenoceptor polymorphisms. Trends Pharmacol. Sci. 22, 471-477 (2001).
67. 2-adrenergic receptor subtype diversity: one receptor is not enough. Am. J. Physiol. Regul. Integr.. Comp. Physiol. 283, R287-R295 (2002).
68. 2A-adrenergic receptor subtype. Hypertension 34, 403-407 (1999).
69. t coupling. J. Biol. Chem. 275, 38518-38523 (2000).
70. 2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR). Nucleic Acids Res. 16, 9070 (1988).
71. 2A-adrenergic receptor gene in a Catalan population: description of a new polymorphism in the promoter region. Gene Geogr. 10, 151-159 (1996).
72. 2A-adrenergic receptor gene in psychiatric patients. Am. J. Med. Genet. 81, 405-410 (1998).
73. 2A-adrenergic receptor gene and mood disorders. Neuroreport 9, 1291-1294 (1998).
74. 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am. J. Hypertens. 8, 863-869 (1995).
75. 2C10-adrenergic receptor genotype. Hypertension 27, 1210-1215 (1996).
76. 2-adrenoceptor restriction fragment length polymorphisms in normotensive and hypertensive humans. J. Hypertens. 10, 1011-1015 (1992).
77. 2-Adrenergic receptor gene polymorphism and hypertension in blacks. Am. J. Hypertens. 8,390-394 (1995).
78. 2A-adrenoceptor gene polymorphism in the HANE study. Nephrol. Dial. Transplant. 14, 2657-2663 (1999).
79. 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol. Med. 8, 88-94 (2002 ).
80. 2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J. Intern. Med. 251,252-257 (2002).
81. 2A (ADR42A gene. Am. J. Med. Genet. 118B, 110-114 (2003).
82. 2B-adrenoceptor gene with schizophrenia and clozapine response. Schizophr. Res. 49, 53-58 (2001).
83. 2A-adrenergic receptor in attention-deficit hyperactivity disorder families. Am. J. Med. Genet. 105, 159-162 (2001).
84. 2A-adrenergic receptor gene and panic disorders. Psychiatry Res. 93, 79-82 (2000).
85. 2-adrenoceptors control vascular development at the interface between mother and embryo. Nat. Genet. 31, 311-315 (2002).
86. 2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension 33, 14-17 (1999).
87. 2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J. Clin. Endocrinol. Metab. 84, 2429-2433 (1999).
88. 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J. Biol. Chem. 276, 4917-4922 (2001).
89. 2B-Adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J. Clin. Endocrinol. Metab. 88, 1184-1187 (2003).
90. 2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. Clin. Sci. (Lond.) 103, 517-524 (2002).
91. 2B-adrenergic receptor deletion/insertion polymorphism in morbid obesity. Clin. Auton. Res. 13, 203-207 (2003).
92. 2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J. Am. Coll. Cardiol. 37, 1516-1522 (2001).
93. 2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J. Am. Coll. Cardiol. 41, 190-194 (2003).
94. 2B-adrenergic receptor and lack of linkage with essential hypertension. Am. J. Hypertens. 12, 853-857 (1999).
95. 2B-adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension 43, 592-597 (2004).
96. 2B-adrenergic receptor gene. Biochem. Pharmacol. 67, 469-478 (2004).
97. 2-adrenoceptor subtypes. Mol. Endocrinol. 17, 1640-1646 (2003).
98. 2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402, 181-184 (1999).
99. 2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106, 2491-2496 (2002).
100. 2C-adrenergic receptor confers impaired coupling to multiple effectors. J. Biol. Chem. 275, 23059-23064 (2000).
101. Evans WE, McLeod HL: Pharmacogenomics - drug disposition, drug targets, and side effects. N. Engl. J. Med. 348, 538-549 (2003).
102. Tregouet DA, Barbaux S, Escolano S et al.: Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum. Mol. Genet. 11, 2015-2023 (2002).
103. The International HapMap Project. Nature 426, 789-796 (2003).
104. Arranz MJ, Munro J, Birkett J et al.: Pharmacogenetic prediction of clozapine response. Lancet 355, 1615-1616 (2000).
105. 2B-adrenoceptor gene polymorphisms on fat mass in Caucasian women. Diabetes 50, 91-95 (2001).
106. 2-adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 53, 829-837 (2004).
107. Iannone MA, Taylor JD, Chen J et al.: Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. Cytometry 39, 131-140 (2000).
108. Ahmadian A, Gharizadeh B, Gustafsson AC et al.: Single-nucleotide polymorphism analysis by pyrosequencing. Anal. Biochem. 280, 103-110 (2000).
109. Brightwell G, Wycherley R, Waghorn A: SNP genotyping using a simple and rapid single-tube modification of ARMS illustrated by analysis of 6 SNPs in a population of males with FRAXA repeat expansions. Mol. Cell. Probes 16, 297-305 (2002).
110. Hacia JG, Fan JB, Ryder O et al.: Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat. Genet. 22, 164-167 (1999).
111. Wang DG, Fan JB, Siao CJ et al.: Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077-1082 (1998).
112. Bray MS, Boerwinkle E, Doris PA: High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum. Mutat. 17, 296-304 (2001).
113. Korstanje R, Paigen B: From QTL to gene: the harvest begins. Nat. Genet. 31, 235-236 (2002).
114. Glazier AM, Nadeau JH, Aitman TJ: Finding genes that underlie complex traits. Science 298, 2345-2349 (2002).
115. Loots GG, Locksley RM, Blankespoor CM et al.: Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288, 136-140 (2000).
116. 2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101, 1707-1714 (2000).
117. Liggett SB: Pharmacogenetic applications of the Human Genome Project. Nat. Med. 7, 281-283 (2001).
118. Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J: Psychiatric genetics: search for phenotypes. Trends Neurosci. 21, 102-105 (1998).